Skip to main content

Advertisement

Log in

The serotonin transporter protein is expressed in psoriasis, where it may play a role in regulating apoptosis

  • Original Paper
  • Published:
Archives of Dermatological Research Aims and scope Submit manuscript

Abstract

Since the symptoms of psoriasis may be changed by treatment with selective serotonin reuptake inhibitors (SSRIs), the expression of serotonin (5-HT) and its transporter protein (SERT) in the skin of patients with psoriasis were examined employing a biotinylated-streptavidine procedure. In biopsies of such skin staining for 5-HT was limited to platelets; the expression of SERT in the keratinocytes of involved regions was redistributed; the numbers of SERT-positive dendritic or round mononuclear cells in the epidermis of involved psoriatic skin were higher than in normal healthy control skin; and the dermis of the involved skin contained higher numbers of round inflammatory cells immunostained for SERT than either non-involved psoriatic skin or normal skin. Double-immunostaining indicated that the skin cells expressing SERT also expressed CD1a, CD3 or tryptase. In addition, SERT immunostaining was co localized with caspase-3, a key regulator of apoptosis, but not with TUNEL staining. The present findings indicate that SERT might play a role in regulating apoptosis in inflammatory cells associated with psoriasis, in which case this protein might constitute a valuable therapeutic target.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8
Fig. 9
Fig. 10

Similar content being viewed by others

References

  1. Blay SL (2006) Depression and psoriasis co morbidity. Treatment with paroxetine: two case reports. Ann Clin Psychiatry 18:271–272. doi:10.1080/10401230600948522

    Article  Google Scholar 

  2. Camilleri M, Andrews CN, Bharucha AE, Carlson PJ, Ferber I, Stephens D, Smyrk TC, Urrutia R, Aerssens J, Thielemans L, Göhlmann H, van den Wyngaert I, Coulie B (2007) Alterations in expression of p11 and SERT in mucosal biopsy specimens of patients with irritable bowel syndrome. Gastroenterology 132:437–441. doi:10.1053/j.gastro.2006.12.014

    Article  Google Scholar 

  3. Coates MD, Mahoney CR, Linden DR, Sampson JE, Chen J, Blaszyk H, Crowell D, Sharkey KA, Gershon MD, Mawe GM, Moses PL (2004) Molecular defects in mucosal serotonin content and decreased serotonin reuptake transporter in ulcerative colitis and irritable bowel syndrome. Gastroenterology 126:1657–1664. doi:10.1053/j.gastro.2004.03.013

    Article  PubMed  CAS  Google Scholar 

  4. El-Nour H, Lundeberg L, Abdel-Magid N, Lonne-Rahm SB, Azmitia EC, Nordlind K (2007) Serotonergic mechanisms in human allergic contact dermatitis. Acta Derm Venereol Stockh 87:390–396. doi:10.2340/00015555-0288

    Article  PubMed  CAS  Google Scholar 

  5. Griffiths CEM, Richards HL (2001) Psychological influences in psoriasis. Clin Exp Dermatol 26:338–342. doi:10.1046/j.1365-2230.2001.00834.x

    Article  PubMed  CAS  Google Scholar 

  6. Hemlock C, Rosenthal JS, Winston A (1992) Fluoxetine-induced psoriasis. Ann Pharmacother 26:211–212

    PubMed  CAS  Google Scholar 

  7. Huang J, Li G, Xiang J, Yin D, Chi R (2004) Immunohistochemical study of serotonin in lesions of psoriasis. Int J Dermatol 43:408–411. doi:10.1111/j.1365-4632.2004.02195.x

    Article  PubMed  CAS  Google Scholar 

  8. Kerckhoffs AP, Ter Linde JJM, Akkermans LMA, Samsom M (2008) Trypsinogen IV, serotonin transporter transcript levels and serotonin content are increased in small intestine of irritable bowel syndrome patients. Neurogastroenterol Motil 20:900–907. doi:10.1111/j.1365-2982.2008.01100.x

    Article  PubMed  CAS  Google Scholar 

  9. Leo R, Di Lorenzo G, Tesauro M, Razzini C, Forleo GB, Chiricolo G, Cola C, Zanasi M, Troisi A, Siracusano A, Lauro R, Romeo F (2006) Association between enhanced soluble CD40 ligand and proinflammatory and prothrombotic states in major depressive disorder: pilot observations on the effects of selective serotonin reuptake inhibitor therapy. J Clin Psychiatry 67:1760–1766

    Article  PubMed  CAS  Google Scholar 

  10. Linden DR, Chen J-X, Gershon MD, Sharkey KA, Mawe GM (2003) Serotonin availability is increased in mucosa of guinea pigs with TNBS-induced colitis. Am J Physiol Gastrointest Liver Physiol 285:G207–G216

    PubMed  CAS  Google Scholar 

  11. Lonne-Rahm SB, Rickberg H, El-Nour H, Mårin P, Azmitia EC, Nordlind K (2008) Neuroimmune mechanisms in patients with atopic dermatitis during chronic stress. J Eur Acad Dermatol Venereol 22:11–18

    PubMed  CAS  Google Scholar 

  12. Modell JG, Boyce S, Taylor E, Katholi C (2002) Treatment of atopic dermatitis and psoriasis vulgaris with bupropion-SR: a pilot study. Psychosom Med 64:835–840. doi:10.1097/01.PSY.0000021954.59258.9B

    Article  PubMed  CAS  Google Scholar 

  13. Nordlind K, Thorslund K, Lonne-Rahm SB, Mohabbati S, Berki T, Morales M, Azmitia EC (2006) Expression of serotonergic receptors in psoriatic skin. Arch Dermatol Res 298:99–106. doi:10.1007/s00403-006-0652-6

    Article  PubMed  CAS  Google Scholar 

  14. Nordlind K, Azmitia EC, Slominski A (2008) The skin as a mirror of the soul: exploring the possible roles of serotonin. Exp Dermatol 17:301–311. doi:10.1111/j.1600-0625.2007.00670.x

    Article  PubMed  CAS  Google Scholar 

  15. O’Connell PJ, Wang X, Leon-Ponte M, Griffiths C, Pingle SC, Ahern GP (2006) A novel form of immune signalling revealed by transmission of the inflammatory mediator serotonin between dendritic cells and T cells. Blood 107:1010–1017. doi:10.1182/blood-2005-07-2903

    Article  PubMed  CAS  Google Scholar 

  16. Osborne SF, Stafford L, Orr KGD (2002) Paroxetine-associated psoriasis. Am J Psychiatry 159:2113. doi:10.1176/appi.ajp.159.12.2113

    Article  PubMed  Google Scholar 

  17. Persico AM, Baldi A, Dell Ácqua ML, Moessner R, Murphy DL, Lesch KP, Keller F (2003) Reduced programmed cell death in brains of serotonin transporter knockout mice. Neuroreport 14:341–344. doi:10.1097/00001756-200303030-00009

    Article  PubMed  CAS  Google Scholar 

  18. Peters BP, Weissman FG, Gill MA (2000) Pathophysiology and treatment of psoriasis. Am J Health Syst Pharm 57:645–659

    PubMed  CAS  Google Scholar 

  19. Slominski A, Pisarchik A, Zbytek B, Tobin DJ, Kauser S, Wortsman J (2003) Functional activity of serotonergic and melatonergic systems expressed in the skin. J Cell Physiol 196:144–153. doi:10.1002/jcp.10287

    Article  PubMed  CAS  Google Scholar 

  20. Slominski A, Wortsman J, Tobin DJ (2005) The cutaneous serotonergic/melatonergic system: securing a place under the sun. FASEB J 19:176–194. doi:10.1096/fj.04-2079rev

    Article  PubMed  CAS  Google Scholar 

  21. Tan B, Foley P (2004) Guttate psoriasis following ecstasy ingestion. Australas J Dermatol 45:167–169. doi:10.1111/j.1440-0960.2004.00080.x

    Article  PubMed  Google Scholar 

  22. Thorslund K, Nordlind K (2007) Serotonergic drugs—a possible role in the treatment of psoriasis? Drug News Perspect 20:521–525. doi:10.1358/dnp.2007.20.8.1157614

    Article  PubMed  CAS  Google Scholar 

  23. Tsao CW, Lin YS, Cheng JT, Lin CF, Wu HT, Wu SR, Tsai WH (2008) Interferon-α-induced serotonin uptake in Jurkat T cells via mitogen-activated protein kinase and transcriptional regulation of the serotonin transporter. J Psychopharmacol 22:753–760. doi:10.1177/0269881107082951

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Kristofer Thorslund.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Thorslund, K., El-Nour, H. & Nordlind, K. The serotonin transporter protein is expressed in psoriasis, where it may play a role in regulating apoptosis. Arch Dermatol Res 301, 449–457 (2009). https://doi.org/10.1007/s00403-009-0933-y

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00403-009-0933-y

Keywords

Navigation